Clal Biotechnology Industries Ltd. (TLV: CBI)

CBI Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 12, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	61	62	98	185	319	211
Market Cap Growth	-36.70%	-36.78%	-46.87%	-41.79%	51.02%	-51.47%
Enterprise Value	97	109	144	336	496	419
Last Close Price	0.39	0.40	0.63	1.18	1.75	1.16
PE Ratio	-	-2.01	-1.60	-2.09	2.60	-1.21
PS Ratio	2131.87	598.73	266.21	827.64	1546.13	1.86
PB Ratio	1.02	0.51	0.68	0.55	0.62	0.42
P/FCF Ratio	-6.35	-7.31	-1.63	-4.32	-8.75	8.72
P/OCF Ratio	-6.35	-7.31	-1.67	-4.49	-9.59	7.80
EV/Sales Ratio	2986.96	1046.55	389.64	1498.60	2405.76	3.70
EV/EBITDA Ratio	-11.85	-10.85	31.35	34.02	37.47	48.87
EV/EBIT Ratio	-11.76	-10.69	-11.53	-26.55	-46.57	-33.72
EV/FCF Ratio	-11.87	-12.78	-2.39	-7.82	-13.61	17.33
Debt / Equity Ratio	0.28	0.29	0.25	0.16	0.10	0.13
Debt / EBITDA Ratio	-	-	7.15	5.45	3.84	7.30
Debt / FCF Ratio	-2.87	-4.20	-0.61	-1.25	-1.40	2.59
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.14
Inventory Turnover	-	-	-	-	-	9.75
Quick Ratio	2.18	2.01	4.65	1.70	6.95	3.14
Current Ratio	2.18	2.21	5.71	2.18	7.46	3.35
Return on Equity (ROE)	-60.69%	-21.10%	-16.98%	-15.63%	25.13%	-47.78%
Return on Assets (ROA)	-3.36%	-3.73%	-2.49%	-1.49%	-1.08%	-0.95%
Return on Capital (ROIC)	-3.42%	-3.76%	-2.72%	-1.65%	-1.18%	-1.05%
Earnings Yield	-109.71%	-49.87%	-62.68%	-48.32%	34.23%	-73.07%
FCF Yield	-15.75%	-13.68%	-61.23%	-23.15%	-11.43%	11.47%
Dividend Yield	0.00%	-	-	-	12.54%	-
Buyback Yield / Dilution	-24.92%	-	1.01%	1.74%	-0.01%	-1.70%
Total Shareholder Return	-24.92%	-	1.01%	1.74%	12.53%	-1.70%

Source: S&P Capital IQ. Standard template. Financial Sources.